Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
31,241
+3,501
+13% +$1.2M 1.18% 18
2026
Q1
$9.76M Buy
27,740
+13,836
+100% +$4.93M 0.93% 26
2025
Q4
$4.55M Buy
13,904
+3,023
+28% +$959K 0.61% 54
2025
Q3
$3.07M Buy
10,881
+1,044
+11% +$303K 0.44% 62
2025
Q2
$2.75M Buy
9,837
+3,314
+51% +$939K 0.45% 62
2025
Q1
$2.03M Sell
6,523
-284
-4% -$83.9K 0.42% 68
2024
Q4
$1.77M Sell
6,807
-379
-5% -$112K 0.39% 64
2024
Q3
$2.32M Buy
7,186
+1,190
+20% +$389K 0.63% 49
2024
Q2
$1.87M Sell
5,996
-1,856
-24% -$545K 0.56% 52
2024
Q1
$2.23M Buy
7,852
+2,129
+37% +$623K 0.73% 40
2023
Q4
$1.65M Buy
5,723
+4,718
+469% +$1.29M 0.68% 42
2023
Q3
$1.54M Sell
1,005
-7,291
-88% -$1.82M 0.72% 45
2023
Q2
$1.82M Sell
8,296
-11,870
-59% -$2.75M 0.89% 41
2023
Q1
$4.88M Buy
20,166
+2,129
+12% +$523K 2.69% 5
2022
Q4
$4.74M Buy
18,037
+151
+0.8% +$40.5K 2.95% 7
2022
Q3
$4.03M Sell
17,886
-75
-0.4% -$18.2K 2.77% 6
2022
Q2
$4.37M Buy
17,961
+1,441
+9% +$353K 3.17% 3
2022
Q1
$4M Buy
16,520
+6,771
+69% +$1.56M 2.3% 7
2021
Q4
$2.19M Buy
9,749
+4,984
+105% +$1.05M 1.53% 23
2021
Q3
$1.01M Sell
4,765
-5,292
-53% -$1.22M 2.56% 11
2021
Q2
$2.45M Buy
10,057
+1,673
+20% +$412K 2.27% 12
2021
Q1
$2.09M Sell
8,384
-1,327
-14% -$317K 2.15% 16
2020
Q4
$2.23M Sell
9,711
-140
-1% -$32.3K 1.53% 15
2020
Q3
$2.5M Sell
9,851
-1,604
-14% -$397K 2.02% 11
2020
Q2
$2.7M Sell
11,455
-3,127
-21% -$713K 2.45% 12
2020
Q1
$2.96M Buy
14,582
+904
+7% +$197K 3.32% 5
2019
Q4
$3.3M Buy
+13,678
New +$3.02M 2.89% 2

Other funds holding AMGN

L2 Asset Management's AMGN Position: Q2 2026 in Review

L2 Asset Management increased its Amgen (AMGN) stake by 13% in Q2 2026, buying an estimated $1.2M and bringing the position to 31,241 shares worth $11.3M. The position accounts for 1.18% of the portfolio, ranked #18.

L2 Asset Management first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • L2 Asset Management held 31,241 shares of Amgen worth $11.3M as of Q2 2026.
  • L2 Asset Management bought 3,501 Amgen shares in Q2 2026, an estimated $1.2M.
  • Amgen made up 1.18% of L2 Asset Management's portfolio in Q2 2026, its #18 holding.
  • L2 Asset Management first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.